160 related articles for article (PubMed ID: 11960919)
21. Superinduction of mouse epidermal ornithine decarboxylase activity by repeated 12-o-tetradecanoylphorbol-13-acetate treatments.
Verma AK; Hsiao KM; Ahrens H; Suganuma M; Fujiki H; Matsufuji S; Hayashi H
Mol Cell Biochem; 1996 Feb; 155(2):139-51. PubMed ID: 8700159
[TBL] [Abstract][Full Text] [Related]
22. Modulation of chrysarobin skin tumor promotion.
DiGiovanni J; Kruszewski FH; Chenicek KJ
Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
[TBL] [Abstract][Full Text] [Related]
23. The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals.
Miller TJ; Honchel R; Espandiari P; Knapton A; Zhang J; Sistare FD; Hanig JP
Regul Toxicol Pharmacol; 2008 Feb; 50(1):87-97. PubMed ID: 18069108
[TBL] [Abstract][Full Text] [Related]
24. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
25. Specific binding, stimulation of rodent urinary bladder epithelial ornithine decarboxylase, and induction of transitional cell hyperplasia by the skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Ertürk E; Bryan GT
Cancer Res; 1983 Dec; 43(12 Pt 1):5964-71. PubMed ID: 6315223
[TBL] [Abstract][Full Text] [Related]
26. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice.
Megosh L; Halpern M; Farkash E; O'Brien TG
Mol Carcinog; 1998 Jul; 22(3):145-9. PubMed ID: 9688139
[TBL] [Abstract][Full Text] [Related]
27. K6/ODC transgenic mice as a sensitive model for carcinogen identification.
Chen Y; Megosh LC; Gilmour SK; Sawicki JA; O'Brien TG
Toxicol Lett; 2000 Jul; 116(1-2):27-35. PubMed ID: 10906419
[TBL] [Abstract][Full Text] [Related]
28. Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice.
Jansen AP; Dreckschmidt NE; Verwiebe EG; Wheeler DL; Oberley TD; Verma AK
Int J Cancer; 2001 Sep; 93(5):635-43. PubMed ID: 11477572
[TBL] [Abstract][Full Text] [Related]
29. Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben.
Verma AK; Conrad EA; Boutwell RK
Carcinogenesis; 1980 Jul; 1(7):607-11. PubMed ID: 11219836
[TBL] [Abstract][Full Text] [Related]
30. Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis.
Wang X; Feith DJ; Welsh P; Coleman CS; Lopez C; Woster PM; O'Brien TG; Pegg AE
Carcinogenesis; 2007 Nov; 28(11):2404-11. PubMed ID: 17675337
[TBL] [Abstract][Full Text] [Related]
31. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
Guo Y; Cleveland JL; O'Brien TG
Cancer Res; 2005 Feb; 65(4):1146-9. PubMed ID: 15734996
[TBL] [Abstract][Full Text] [Related]
32. Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene.
Halmekytö M; Syrjänen K; Jänne J; Alhonen L
Biochem Biophys Res Commun; 1992 Aug; 187(1):493-7. PubMed ID: 1520339
[TBL] [Abstract][Full Text] [Related]
33. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Verma AK; Pong RC; Erickson D
Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
[TBL] [Abstract][Full Text] [Related]
34. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10.
Sundberg JP; Erickson AA; Roop DR; Binder RL
Cancer Res; 1994 Mar; 54(5):1344-51. PubMed ID: 7509717
[TBL] [Abstract][Full Text] [Related]
35. Palmitoylcarnitine reverses 12-O-tetradecanoylphorbol-13-acetate-induced refractory state for the TPA-caused ornithine decarboxylase induction in mouse epidermis.
Aizu E; Yamamoto S; Nakadate T; Kiyoto I; Kato R
Carcinogenesis; 1988 Feb; 9(2):309-13. PubMed ID: 3338115
[TBL] [Abstract][Full Text] [Related]
36. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis.
Gilmour SK; Verma AK; Madara T; O'Brien TG
Cancer Res; 1987 Mar; 47(5):1221-5. PubMed ID: 3815331
[TBL] [Abstract][Full Text] [Related]
37. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and tumor promotion by N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) in mouse skin.
Nakadate T; Yamamoto S; Aizu E; Kato R
Pharmacology; 1986; 32(3):167-75. PubMed ID: 3083437
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis.
Feith DJ; Origanti S; Shoop PL; Sass-Kuhn S; Shantz LM
Carcinogenesis; 2006 May; 27(5):1090-8. PubMed ID: 16400186
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis.
Lu YP; Chang RL; Huang MT; Conney AH
Carcinogenesis; 1993 Feb; 14(2):293-7. PubMed ID: 8435870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
